cholesterol Archives -

Scotland says no to Daiichi Sankyo’s cholesterol drug Nilemdo

https://pharmaphorum.com/news/scotland-says-no-to-daiichi-sankyos-cholesterol-drug-nilemdo/

AstraZeneca sells rights to cholesterol drug Crestor to Grunenthal

https://pharmaphorum.com/news/astrazeneca-sells-rights-to-cholesterol-drug-crestor-to-grunenthal/

Novartis’ big bet on inclisiran nears fruition, as CHMP backs drug

https://pharmaphorum.com/news/novartis-big-bet-on-inclisiran-nears-fruition-as-chmp-backs-drug/

AZ buys oral PCSK9 cholesterol drug from Dogma Therapeutics

https://pharmaphorum.com/news/az-buys-oral-pcsk9-cholesterol-drug-from-dogma-therapeutics/

Novartis strikes landmark deal with NHS to speed up inclisiran access

https://pharmaphorum.com/news/novartis-strikes-landmark-deal-with-nhs-to-speed-up-inclisiran-access/

Amgen pulls higher-priced Repatha to try to lift sales

https://pharmaphorum.com/news/amgen-pulls-higher-priced-repatha-to-try-to-lift-sales/

TMC’s inclisiran impresses at ESC, but will it surpass PCSK9 rivals?

https://pharmaphorum.com/news/tmcs-inclisiran-impresses-at-esc-but-will-it-surpass-pcsk9-rivals/

TMC inches closer to inclisiran approval with long-term safety data

https://pharmaphorum.com/news/tmc-inches-closer-to-inclisiran-approval-with-long-term-safety-data/

Merck axes cholesterol drug despite phase 3 success

https://pharmaphorum.com/news/merck-axes-cholesterol-drug-despite-phase-3-success/

Search